Several approaches have been applied on the targeting of CAF-related surface markers, such as FAP and α-SMA [71], since they are highly expressed in a number of tumour tissues, including pancreatic, lung, and breast cancer [72]. The gene discussed is FAP; the disease is breast carcinoma.